Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | VVD-130037 |
| Synonyms | |
| Therapy Description |
VVD-130037 is a small molecule activator of KEAP1, which potentially induces antitumor activity (Cancer Res (2025) 85 (8_Supplement_1): 4349). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| VVD-130037 | VVD130037|VVD 130037 | VVD-130037 is a small molecule activator of KEAP1, which potentially induces antitumor activity (Cancer Res (2025) 85 (8_Supplement_1): 4349). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05954312 | Phase I | VVD-130037 | A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors | Recruiting | USA | ESP | 1 |